The Benefits and Limitations of Clinical Data Platforms
Considerations to help tailor new tools as part of a custom clinical trial strategy.
The Role of Transferable Skills and Data Science in the Move to Digitally-Enabled Clinical Research
Simultaneous and niche skills sought amid evolution in clinical data management.
Progress Report: Pharma Adoption of Data Analytics
Assessing industry’s use and integration of clinical data science across business.
Conflicting Terminology in Digital Health Space: A Call for Consensus
Despite high potential of DHTs, regulatory picture remains unclear.
FDA Interactions With Industry Under the Microscope
Probe targets agency’s role in advising on drug testing and submissions.
2023 SCOPE: It’s an Orlando Thing
Highlights from the annual SCOPE conference held in Orlando, FL.
Applied Clinical Trials January/February 2023 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2023 issue in an interactive PDF format.
Lessons Learned in 2022 and the Impact on Drug Development in the Year Ahead
DCTs and RWD among topics for industry to focus on moving into 2023.
Get it Right Next Time? EU Legislation Under Critical Review
The issues engulfing compliance with the Clinical Trials Regulation signal that even the best intentions with these types of laws may not be enough to avert unintended consequences.
Advances in eSource Interoperability Between EHR and EDC
How evidence generated by the latest IgniteData ‘real-setting’ pilot study supports the case for clinical trial transformation.
Identifying Patient Needs
Sam Whitaker, co-founder and co-CEO of Mural Health discusses his time in the industry and patient needs in the current clinical trials market.
